Since the ERαY537S and ERαD538G cells constitutively express very high levels of PR, the low serum concentrations of progestins in postmenopausal women together with high PR could well have functional effects on antiestrogen resistance in metastatic breast cancers expressing ERα mutations. Here, ESR1 is linked to breast cancer.